TABLE 3.
Comparative in vitro activities of AC98-6446 and other antibiotics against recent streptococcal clinical isolates
| Organism (no. of isolates tested) | Antibiotic | MIC (μg/ml)
|
||
|---|---|---|---|---|
| Range | 50% | 90% | ||
| S. pneumoniae, penicillin resistant (10) | AC98-6446 | ≤0.008 | ≤0.008 | ≤0.008 |
| Vancomycin | 0.25-0.5 | 0.25 | 0.25 | |
| Teicoplanin | ≤0.008-0.03 | ≤0.008 | 0.015 | |
| Tigecycline | 0.25-0.5 | 0.25 | 0.5 | |
| Levofloxacin | 0.5-1 | 1 | 1 | |
| Erythromycin | 0.015-4 | 1 | 4 | |
| Amoxicillin | 1-4 | 2 | 4 | |
| S. pneumoniae, penicillin intermediate (10) | AC98-6446 | ≤0.008 | ≤0.008 | ≤0.008 |
| Vancomycin | 0.25-0.5 | 0.25 | 0.25 | |
| Teicoplanin | ≤0.008-0.015 | ≤0.008 | ≤0.008 | |
| Tigecycline | 0.25-0.5 | 0.5 | 0.5 | |
| Levofloxacin | 1 | 1 | 1 | |
| Erythromycin | 0.015-1 | 0.015 | 0.03 | |
| Amoxicillin | 0.06-0.5 | 0.25 | 0.25 | |
| S. pneumoniae, penicillin susceptible (11) | AC98-6446 | ≤0.008 | ≤0.008 | ≤0.008 |
| Vancomycin | 0.12-0.5 | 0.5 | 0.5 | |
| Teicoplanin | ≤0.008-0.03 | 0.015 | 0.03 | |
| Tigecycline | 0.25-1 | 0.5 | 0.5 | |
| Levofloxacin | 0.5-2 | 1 | 1 | |
| Erythromycin | 0.015-0.03 | 0.03 | 0.03 | |
| Amoxicillin | ≤0.008-0.03 | 0.015 | 0.015 | |
| S. pyogenes (10) | AC98-6446 | ≤0.008-0.06 | 0.015 | 0.03 |
| Vancomycin | 0.25-0.5 | 0.25 | 0.25 | |
| Teicoplanin | ≤0.008-0.015 | ≤0.008 | ≤0.008 | |
| Tigecycline | 0.03-0.12 | 0.12 | 0.12 | |
| Levofloxacin | 0.12-0.5 | 0.25 | 0.5 | |
| Erythromycin | ≤0.008-0.03 | 0.015 | 0.03 | |
| Amoxicillin | ≤0.008-0.015 | ≤0.008 | 0.015 | |
| S. agalactiae (10) | AC98-6446 | ≤0.008-0.03 | 0.015 | 0.03 |
| Vancomycin | 0.25-0.5 | 0.25 | 0.5 | |
| Teicoplanin | ≤0.008-0.06 | 0.03 | 0.06 | |
| Tigecycline | 0.12 | 0.12 | 0.12 | |
| Levofloxacin | 0.5-1 | 1 | 1 | |
| Erythromycin | 0.015-0.06 | 0.03 | 0.06 | |
| Amoxicillin | ≤0.008-0.06 | 0.03 | 0.06 | |